Index of Articles From AIDSinfo
Drug Fact Sheets
- An Overview of Aldesleukin (IL-2, Proleukin) (June 7, 2009)
- An Overview of Aptivus (Tipranavir) (September 13, 2012)
- An Overview of Atripla (Efavirenz/Tenofovir/FTC) (April 18, 2013)
- An Overview of Azithromycin (Zithromax) (October 8, 2012)
- An Overview of BMS-663068 (October 22, 2012)
- An Overview of Cenicriviroc (October 22, 2012)
- An Overview of Clarithromycin (Biaxin) (October 5, 2012)
- An Overview of Clindamycin (October 5, 2012)
- An Overview of Cobicistat (GS-9350) (October 25, 2010)
- An Overview of Combivir (AZT/3TC) (September 13, 2012)
- An Overview of Complera (Rilpivirine/Tenofovir/Emtricitabine) (August 17, 2011)
- An Overview of Dolutegravir (October 11, 2012)
- An Overview of Doxorubicin Hydrochloride (Doxil) (June 8, 2009)
- An Overview of Dronabinol (Marinol) (June 30, 2009)
- An Overview of Edurant (Rilpivirine) (December 11, 2012)
- An Overview of Elvitegravir (October 31, 2012)
- An Overview of Elvucitabine (October 31, 2012)
- An Overview of Emtricitabine (FTC, Emtriva) (September 21, 2012)
- An Overview of Epivir (3TC, Lamivudine) (September 13, 2012)
- An Overview of Epoetin Alfa (Epogen, Procrit) (March 22, 2007)
- An Overview of Epzicom (Abacavir/3TC, Kivexa) (September 13, 2012)
- An Overview of Fluconazole (Diflucan) (November 21, 2012)
- An Overview of Fuzeon (Enfuvirtide, T-20) (September 13, 2012)
- An Overview of Ganciclovir (Cytovene, Vitrasert) (November 14, 2012)
- An Overview of GS-7340 (October 24, 2012)
- An Overview of Ibalizumab (October 22, 2012)
- An Overview of Indinavir (IDV, Crixivan) (September 13, 2012)
- An Overview of Intelence (TMC125, Etravirine) (September 13, 2012)
- An Overview of Interferon Alfa-2 (Roferon-A, Intron A) (March 13, 2007)
- An Overview of Isentress (Raltegravir, MK-0518) (April 22, 2012)
- An Overview of Isoniazid (INH, Nydrazid) (April 30, 2007)
- An Overview of Kaletra (Lopinavir/Ritonavir) (September 13, 2012)
- An Overview of Lersivirine (October 11, 2012)
- An Overview of Lexiva (Fosamprenavir, Telzir) (September 13, 2012)
- An Overview of Norvir (Ritonavir) (September 14, 2012)
- An Overview of PA-457 (November 23, 2008)
- An Overview of Peginterferon Alfa-2 (Pegasys, PEG-Intron) (October 4, 2012)
- An Overview of Poly-L-Lactic Acid (Sculptra, New-Fill) (January 23, 2007)
- An Overview of Prezista (Darunavir, TMC114) (March 5, 2013)
- An Overview of PRO-140 (October 22, 2012)
- An Overview of Racivir (November 2, 2012)
- An Overview of Rescriptor (Delavirdine) (September 13, 2012)
- An Overview of Reyataz (Atazanavir) (September 13, 2012)
- An Overview of Ribavirin (Copegus, Rebetol, Virazole) (February 12, 2007)
- An Overview of Rifabutin (Mycobutin) (October 3, 2012)
- An Overview of Rifampin (Rifadin, Rimactane) (October 2, 2012)
- An Overview of Saquinavir mesylate (Invirase) (September 13, 2012)
- An Overview of Selzentry (Maraviroc, Celsentri) (September 13, 2012)
- An Overview of S/GSK1265744 (October 11, 2012)
- An Overview of Stavudine (d4T, Zerit) (June 8, 2012)
- An Overview of Stribild (Elvitegravir/Cobicistat/FTC/Tenofovir) (November 30, 2012)
- An Overview of Sulfamethoxazole-Trimethaprim (Bactrim, Septra, Sulfatrim) (June 18, 2007)
- An Overview of Sustiva (Efavirenz, Stocrin) (September 13, 2012)
- An Overview of Tenofovir (TDF, Viread) (September 21, 2012)
- An Overview of Tesamorelin (November 11, 2010)
- An Overview of Trizivir (AZT/3TC/Abacavir) (September 13, 2012)
- An Overview of Truvada (Tenofovir/FTC) (September 13, 2012)
- An Overview of Valproic Acid (December 11, 2007)
- An Overview of Videx (Didanosine, ddI) (September 13, 2012)
- An Overview of Viracept (Nelfinavir) (September 13, 2012)
- An Overview of Viramune (Nevirapine) (November 15, 2012)
- An Overview of Ziagen (Abacavir) (September 14, 2012)
- An Overview of Zidovudine (AZT, Retrovir) (September 13, 2012)
Articles
- FDA Updates Efavirenz Labeling With Expanded Pediatric Indication Information (May 7, 2013)
- Updated Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Released (May 7, 2013)
- Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents (PDF) (May 7, 2013)
- HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Seeks Nominations for the Non-Governmental Co-Chair of the Panel (April 19, 2013)
- What's New in the Pediatric Guidelines? (April 3, 2013)
- Today Is National Native HIV/AIDS Awareness Day (March 20, 2013)
- HHS Perinatal Guidelines Panel Accepting Nominations for New Members (February 22, 2013)
- What's New in the U.S. DHHS Antiretroviral Therapy Guidelines for Adults and Adolescents (February 12, 2013)
- Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (February 12, 2013)
To read the PDF, click here.
This document will open on the "What's New in the Guidelines?" page; use the table of contents you'll see on the left to navigate through the guidelines.
- Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (PDF) (November 1, 2012)
- HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Announces New Members (December 21, 2012)
- HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Accepting Nominations for New Members (September 14, 2012)
- NIH/IAS HIV Funding Opportunity Announced (August 17, 2012)
- CDC to Present Live Webcast on High-Impact HIV Prevention (August 17, 2012)
- HIV and Its Treatment (August 2012)
Health information for patients.
To read PDF, click here.
- What's New in the Updated HHS Perinatal Antiretroviral Treatment Guidelines (July 31, 2012)
- Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States (July 31, 2012)
To read the PDF, click here.
- AIDS Memorial Quilt in the White House (July 24, 2012)
- NIAID Issues New Clinical Trials Units Funding Opportunity Announcement (April 20, 2012)
- Corrections to Adult and Adolescent ARV Treatment Guidelines (March 29, 2012)
- Join AIDSinfo in Observing National Native HIV/AIDS Awareness Day (March 16, 2012)
- HIV and Pregnancy (February 2012)
Health information for patients.
To read PDF, click here.
- HHS Guidelines Panels Issue Statement on Treating Latent Tuberculosis Infection in People Infected With HIV Receiving Antiretroviral Therapy (December 20, 2011)
Short-course (3-month) therapy with weekly isoniazid-rifapentine is NOT RECOMMENDED for HIV-infected patients receiving antiretroviral therapy.
- Nominations for New Community Members of the DHHS Panel on Pediatric Antiretroviral Therapy and Management Guidelines (December 5, 2011)
- Glossary of HIV/AIDS-Related Terms (PDF) (October 2011)
- Call for Nominations for New Scientific/Clinical Members for the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents (September 9, 2011)
- Updated HHS "Guidance for Non-HIV-Specialized Providers Caring for HIV-Infected Residents Displaced From Disaster Areas" Now Available (August 26, 2011)
- Guidance for Non-HIV-Specialized Providers Caring for HIV-Infected Residents Displaced From Disaster Areas (PDF) (August 26, 2011)
- "Drugs That Fight HIV" Poster Features Images of Antiretroviral Medications (August 26, 2011)
- DHHS Adult and Adolescent Antiretroviral Treatment Guidelines Panel Releases Supplemental Information Regarding the Role of Rilpivirine as Initial Therapy (August 16, 2011)
To read PDF, click here.
- What's New in the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (January 10, 2011)
- HHS Perinatal Guidelines Panel Accepting Nominations for New Members (November 5, 2010)
- Antiretroviral Formulations (July 2009)
To read PDF, click here.
- What Do I Need to Know About Immunizations? (June 2009)
To read PDF, click here.
- Recommended Immunizations for HIV-Positive Adults (June 2009)
To read PDF, click here.
- DHHS Adults and Adolescents Antiretroviral Treatment Guidelines Panel's Communication Regarding Abacavir (April 4, 2008)
To read PDF, click here.
- Entecavir in Hepatitis B Virus (HBV)/HIV Co-Infected Patients (April 30, 2007)
Supplement to the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents -- October 10, 2006
To read PDF, click here.
- Update on the New York City "Superbug" (August 11, 2006)
- Preventive HIV Vaccines (May 2006)
To read PDF, click here.
- Therapeutic HIV Vaccines (May 2006)
To read PDF, click here.
- Hepatotoxicity (October 2005)
To read PDF, click here.
- Hyperglycemia (October 2005)
To read PDF, click here.
- Hyperlipidemia (October 2005)
To read PDF, click here.
- Lactic Acidosis (October 2005)
To read PDF, click here.
- Lipodystrophy (October 2005)
To read PDF, click here.
- Osteonecrosis, Osteopenia and Osteoporosis (October 2005)
To read PDF, click here.
- Skin Rash (October 2005)
To read PDF, click here.
- What Is an HIV/AIDS Clinical Trial? (September 2005)
To read PDF, click here.
- The HIV Life Cycle (May 2005)
To read PDF, click here.
- FDA Approves Generic Formulation of Didanosine (ddI) Delayed Release Capsules (December 3, 2004)
- Suggestions for Taking the Liquid Formulation of Ritonavir (August 21, 1998)
- HIV Protease Inhibitors & You (December 1997)
- Developing Options for Perinatal HIV Prevention in the Developing World (June 1997)
- Understanding Viral Load (March 1997)
- Caring for Someone With AIDS at Home: A Guide
Hojas en Español
Articulos en Español
|
|
Advertisement
|
Email
Print-Friendly
Glossary
